HEADER TRANSFERASE 15-DEC-20 7L1T TITLE CRYSTAL STRUCTURE OF HUMAN HOLO SEPSECS COMPND MOL_ID: 1; COMPND 2 MOLECULE: O-PHOSPHOSERYL-TRNA(SEC) SELENIUM TRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LIVER-PANCREAS ANTIGEN,LP,SLA-P35,SLA/LP AUTOANTIGEN, COMPND 5 SELENOCYSTEINE SYNTHASE,SEC SYNTHASE,SELENOCYSTEINYL-TRNA(SEC) COMPND 6 SYNTHASE,SEP-TRNA:SEC-TRNA SYNTHASE,SEPSECS,SOLUBLE LIVER ANTIGEN, COMPND 7 SLA,UGA SUPPRESSOR TRNA-ASSOCIATED PROTEIN,TRNA(SER/SEC)-ASSOCIATED COMPND 8 ANTIGENIC PROTEIN; COMPND 9 EC: 2.9.1.2; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SEPSECS, TRNP48; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SELENOCYSTEINE SYNTHESIS, PROTEIN TRANSLATION, PLP-DEPENDENT ENZYME, KEYWDS 2 RNA BINDING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.PUPPALA,J.CASTILLO SUCHKOU,M.SIMONOVIC REVDAT 3 25-OCT-23 7L1T 1 REMARK REVDAT 2 29-MAR-23 7L1T 1 JRNL REVDAT 1 09-FEB-22 7L1T 0 JRNL AUTH A.K.PUPPALA,J.CASTILLO SUCHKOU,R.L.FRENCH,K.A.KIERNAN, JRNL AUTH 2 M.SIMONOVIC JRNL TITL STRUCTURAL BASIS FOR THE TRNA-DEPENDENT ACTIVATION OF THE JRNL TITL 2 TERMINAL COMPLEX OF SELENOCYSTEINE SYNTHESIS IN HUMANS. JRNL REF NUCLEIC ACIDS RES. 2023 JRNL REFN ESSN 1362-4962 JRNL PMID 36929010 JRNL DOI 10.1093/NAR/GKAD182 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_3951 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 25758 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.760 REMARK 3 FREE R VALUE TEST SET COUNT : 1999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.6400 - 5.4200 0.99 1854 156 0.1593 0.1739 REMARK 3 2 5.4200 - 4.3000 1.00 1748 146 0.1494 0.1700 REMARK 3 3 4.3000 - 3.7600 1.00 1727 146 0.1580 0.1874 REMARK 3 4 3.7600 - 3.4200 1.00 1706 143 0.1810 0.2190 REMARK 3 5 3.4200 - 3.1700 1.00 1696 143 0.1958 0.2829 REMARK 3 6 3.1700 - 2.9900 1.00 1694 142 0.2257 0.2890 REMARK 3 7 2.9900 - 2.8400 1.00 1675 141 0.2330 0.3271 REMARK 3 8 2.8400 - 2.7100 1.00 1680 142 0.2448 0.3143 REMARK 3 9 2.7100 - 2.6100 1.00 1670 140 0.2536 0.3200 REMARK 3 10 2.6100 - 2.5200 1.00 1678 141 0.2773 0.3573 REMARK 3 11 2.5200 - 2.4400 1.00 1670 141 0.3057 0.3328 REMARK 3 12 2.4400 - 2.3700 1.00 1668 140 0.3155 0.3751 REMARK 3 13 2.3700 - 2.3100 1.00 1650 139 0.3354 0.3622 REMARK 3 14 2.3100 - 2.2500 0.98 1643 139 0.3882 0.3980 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.410 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.620 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7L1T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1000252440. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : 6.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0333 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25765 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 8.500 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.90 REMARK 200 R MERGE FOR SHELL (I) : 0.88900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: 3HL2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.36 M LITHIUM CITRATE, 15% PEG 3,350, REMARK 280 0.1 M SODIUM CACODYLIC ACID, 0.04 M HCL 4 MG/ML SEPSECS, 1 MG/ML REMARK 280 HUMAN TRNASEC, PH 6.3, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 285K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 6 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z REMARK 290 6555 X-Y,X,Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z REMARK 290 10555 -Y,-X,-Z REMARK 290 11555 -X+Y,Y,-Z REMARK 290 12555 X,X-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1189 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 ARG A 3 REMARK 465 GLU A 4 REMARK 465 SER A 5 REMARK 465 PHE A 6 REMARK 465 ALA A 7 REMARK 465 ARG A 465 REMARK 465 SER A 466 REMARK 465 LYS A 467 REMARK 465 GLU A 468 REMARK 465 SER A 469 REMARK 465 ASP A 470 REMARK 465 ASP A 471 REMARK 465 ASN A 472 REMARK 465 TYR A 473 REMARK 465 ASP A 474 REMARK 465 LYS A 475 REMARK 465 THR A 476 REMARK 465 GLU A 477 REMARK 465 ASP A 478 REMARK 465 VAL A 479 REMARK 465 ASP A 480 REMARK 465 ILE A 481 REMARK 465 GLU A 482 REMARK 465 GLU A 483 REMARK 465 MET A 484 REMARK 465 ALA A 485 REMARK 465 LEU A 486 REMARK 465 LYS A 487 REMARK 465 LEU A 488 REMARK 465 ASP A 489 REMARK 465 ASN A 490 REMARK 465 VAL A 491 REMARK 465 LEU A 492 REMARK 465 LEU A 493 REMARK 465 ASP A 494 REMARK 465 THR A 495 REMARK 465 TYR A 496 REMARK 465 GLN A 497 REMARK 465 ASP A 498 REMARK 465 ALA A 499 REMARK 465 SER A 500 REMARK 465 SER A 501 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 12 CG CD1 CD2 REMARK 470 SER A 14 OG REMARK 470 ARG A 19 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 23 CG CD OE1 OE2 REMARK 470 ARG A 26 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 29 CG CD OE1 OE2 REMARK 470 LYS A 38 CD CE NZ REMARK 470 LYS A 107 CD CE NZ REMARK 470 LYS A 116 CD CE NZ REMARK 470 LYS A 161 CG CD CE NZ REMARK 470 LYS A 163 CD CE NZ REMARK 470 LYS A 203 CE NZ REMARK 470 LYS A 261 CD CE NZ REMARK 470 LYS A 353 CE NZ REMARK 470 LYS A 354 CE NZ REMARK 470 LYS A 378 CE NZ REMARK 470 ARG A 384 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 386 CG CD CE NZ REMARK 470 LYS A 443 CD CE NZ REMARK 470 ARG A 456 CD NE CZ NH1 NH2 REMARK 470 LYS A 463 CE NZ REMARK 470 GLU A 464 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 224 -76.90 -97.05 REMARK 500 ASN A 253 52.45 -113.19 REMARK 500 LEU A 380 -86.17 -132.03 REMARK 500 GLU A 382 57.45 -93.49 REMARK 500 HIS A 383 -52.91 66.37 REMARK 500 MET A 423 -1.54 71.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FIRST 20 AMINO ACIDS CORRESPOND TO THE HIS-TAG AND ITS LINKER. REMARK 999 RESIDUE 1 OF THE PROTEIN BEGINS AT RESIDUE 21 OF THE SEQUENCE. DBREF 7L1T A 1 501 UNP Q9HD40 SPCS_HUMAN 1 501 SEQADV 7L1T MET A -19 UNP Q9HD40 INITIATING METHIONINE SEQADV 7L1T GLY A -18 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T SER A -17 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T SER A -16 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T HIS A -15 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T HIS A -14 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T HIS A -13 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T HIS A -12 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T HIS A -11 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T HIS A -10 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T SER A -9 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T SER A -8 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T GLY A -7 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T LEU A -6 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T VAL A -5 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T PRO A -4 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T ARG A -3 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T GLY A -2 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T SER A -1 UNP Q9HD40 EXPRESSION TAG SEQADV 7L1T HIS A 0 UNP Q9HD40 EXPRESSION TAG SEQRES 1 A 521 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 521 LEU VAL PRO ARG GLY SER HIS MET ASN ARG GLU SER PHE SEQRES 3 A 521 ALA ALA GLY GLU ARG LEU VAL SER PRO ALA TYR VAL ARG SEQRES 4 A 521 GLN GLY CYS GLU ALA ARG ARG SER HIS GLU HIS LEU ILE SEQRES 5 A 521 ARG LEU LEU LEU GLU LYS GLY LYS CYS PRO GLU ASN GLY SEQRES 6 A 521 TRP ASP GLU SER THR LEU GLU LEU PHE LEU HIS GLU LEU SEQRES 7 A 521 ALA ILE MET ASP SER ASN ASN PHE LEU GLY ASN CYS GLY SEQRES 8 A 521 VAL GLY GLU ARG GLU GLY ARG VAL ALA SER ALA LEU VAL SEQRES 9 A 521 ALA ARG ARG HIS TYR ARG PHE ILE HIS GLY ILE GLY ARG SEQRES 10 A 521 SER GLY ASP ILE SER ALA VAL GLN PRO LYS ALA ALA GLY SEQRES 11 A 521 SER SER LEU LEU ASN LYS ILE THR ASN SER LEU VAL LEU SEQRES 12 A 521 ASP ILE ILE LYS LEU ALA GLY VAL HIS THR VAL ALA ASN SEQRES 13 A 521 CYS PHE VAL VAL PRO MET ALA THR GLY MET SER LEU THR SEQRES 14 A 521 LEU CYS PHE LEU THR LEU ARG HIS LYS ARG PRO LYS ALA SEQRES 15 A 521 LYS TYR ILE ILE TRP PRO ARG ILE ASP GLN LYS SER CYS SEQRES 16 A 521 PHE LYS SER MET ILE THR ALA GLY PHE GLU PRO VAL VAL SEQRES 17 A 521 ILE GLU ASN VAL LEU GLU GLY ASP GLU LEU ARG THR ASP SEQRES 18 A 521 LEU LYS ALA VAL GLU ALA LYS VAL GLN GLU LEU GLY PRO SEQRES 19 A 521 ASP CYS ILE LEU CYS ILE HIS SER THR THR SER CYS PHE SEQRES 20 A 521 ALA PRO ARG VAL PRO ASP ARG LEU GLU GLU LEU ALA VAL SEQRES 21 A 521 ILE CYS ALA ASN TYR ASP ILE PRO HIS ILE VAL ASN ASN SEQRES 22 A 521 ALA TYR GLY VAL GLN SER SER LYS CYS MET HIS LEU ILE SEQRES 23 A 521 GLN GLN GLY ALA ARG VAL GLY ARG ILE ASP ALA PHE VAL SEQRES 24 A 521 GLN SER LEU ASP LYS ASN PHE MET VAL PRO VAL GLY GLY SEQRES 25 A 521 ALA ILE ILE ALA GLY PHE ASN ASP SER PHE ILE GLN GLU SEQRES 26 A 521 ILE SER LYS MET TYR PRO GLY ARG ALA SER ALA SER PRO SEQRES 27 A 521 SER LEU ASP VAL LEU ILE THR LEU LEU SER LEU GLY SER SEQRES 28 A 521 ASN GLY TYR LYS LYS LEU LEU LYS GLU ARG LYS GLU MET SEQRES 29 A 521 PHE SER TYR LEU SER ASN GLN ILE LYS LYS LEU SER GLU SEQRES 30 A 521 ALA TYR ASN GLU ARG LEU LEU HIS THR PRO HIS ASN PRO SEQRES 31 A 521 ILE SER LEU ALA MET THR LEU LYS THR LEU ASP GLU HIS SEQRES 32 A 521 ARG ASP LYS ALA VAL THR GLN LEU GLY SER MET LEU PHE SEQRES 33 A 521 THR ARG GLN VAL SER GLY ALA ARG VAL VAL PRO LEU GLY SEQRES 34 A 521 SER MET GLN THR VAL SER GLY TYR THR PHE ARG GLY PHE SEQRES 35 A 521 MET SER HIS THR ASN ASN TYR PRO CYS ALA TYR LEU ASN SEQRES 36 A 521 ALA ALA SER ALA ILE GLY MET LYS MET GLN ASP VAL ASP SEQRES 37 A 521 LEU PHE ILE LYS ARG LEU ASP ARG CYS LEU LYS ALA VAL SEQRES 38 A 521 ARG LYS GLU ARG SER LYS GLU SER ASP ASP ASN TYR ASP SEQRES 39 A 521 LYS THR GLU ASP VAL ASP ILE GLU GLU MET ALA LEU LYS SEQRES 40 A 521 LEU ASP ASN VAL LEU LEU ASP THR TYR GLN ASP ALA SER SEQRES 41 A 521 SER HET PLR A1001 15 HET PO4 A1002 5 HETNAM PLR (5-HYDROXY-4,6-DIMETHYLPYRIDIN-3-YL)METHYL DIHYDROGEN HETNAM 2 PLR PHOSPHATE HETNAM PO4 PHOSPHATE ION HETSYN PLR 4'-DEOXYPYRIDOXINE PHOSPHATE FORMUL 2 PLR C8 H12 N O5 P FORMUL 3 PO4 O4 P 3- FORMUL 4 HOH *96(H2 O) HELIX 1 AA1 SER A 14 GLY A 39 1 26 HELIX 2 AA2 ASP A 47 MET A 61 1 15 HELIX 3 AA3 ASP A 62 PHE A 66 5 5 HELIX 4 AA4 SER A 81 HIS A 88 1 8 HELIX 5 AA5 ALA A 108 GLY A 130 1 23 HELIX 6 AA6 ALA A 143 ARG A 159 1 17 HELIX 7 AA7 GLN A 172 ALA A 182 1 11 HELIX 8 AA8 ASP A 201 GLY A 213 1 13 HELIX 9 AA9 ARG A 234 ASP A 246 1 13 HELIX 10 AB1 SER A 259 GLY A 273 1 15 HELIX 11 AB2 LEU A 282 MET A 287 1 6 HELIX 12 AB3 ASN A 299 MET A 309 1 11 HELIX 13 AB4 ALA A 316 TYR A 359 1 44 HELIX 14 AB5 LYS A 386 ARG A 398 1 13 HELIX 15 AB6 LYS A 443 GLU A 464 1 22 SHEET 1 AA1 7 ASN A 136 VAL A 140 0 SHEET 2 AA1 7 ALA A 293 GLY A 297 -1 O ALA A 293 N VAL A 140 SHEET 3 AA1 7 ALA A 277 SER A 281 -1 N PHE A 278 O ALA A 296 SHEET 4 AA1 7 HIS A 249 ASN A 252 1 N VAL A 251 O ALA A 277 SHEET 5 AA1 7 ILE A 217 THR A 223 1 N SER A 222 O ASN A 252 SHEET 6 AA1 7 TYR A 164 PRO A 168 1 N TYR A 164 O LEU A 218 SHEET 7 AA1 7 GLU A 185 ILE A 189 1 O VAL A 187 N ILE A 165 SHEET 1 AA2 2 VAL A 192 GLU A 194 0 SHEET 2 AA2 2 GLU A 197 ARG A 199 -1 O GLU A 197 N GLU A 194 SHEET 1 AA3 3 SER A 372 THR A 376 0 SHEET 2 AA3 3 TYR A 433 ALA A 437 -1 O ALA A 436 N LEU A 373 SHEET 3 AA3 3 VAL A 405 VAL A 406 -1 N VAL A 406 O TYR A 433 SHEET 1 AA4 2 MET A 411 VAL A 414 0 SHEET 2 AA4 2 TYR A 417 ARG A 420 -1 O PHE A 419 N GLN A 412 LINK NZ LYS A 284 C4A PLR A1001 1555 1555 1.35 CISPEP 1 ALA A 228 PRO A 229 0 4.13 CRYST1 154.216 154.216 76.257 90.00 90.00 120.00 P 6 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006484 0.003744 0.000000 0.00000 SCALE2 0.000000 0.007488 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013114 0.00000